)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Glenmark Pharmaceuticals (GLENMARK) investor relations material
Glenmark Pharmaceuticals Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary18 Aug, 2025
Executive summary
Consolidated revenue for Q1 FY26 was INR 32,644 million, up 0.6% year-over-year, with strong India and North America growth offset by Europe and emerging markets declines.
India formulation business grew 3.7% year-over-year, led by cardiac, respiratory, and dermatology segments.
North America revenue rose 8.9% sequentially to INR 7,718 million (US$91 million), driven by injectable launches and partnerships.
Europe revenue declined 4% year-over-year, but branded respiratory products and new launches are expected to drive future growth.
Emerging markets revenue was nearly flat year-over-year, with strong Russia and APAC growth offset by seasonality in Latin America.
Financial highlights
Gross margin for Q1 FY26 was 68.9%, up from 65.8% year-over-year.
EBITDA margin was 17.8% for Q1 FY26, with expectations to stabilize at 23%+ from Q3 onwards.
Net debt at quarter-end was around INR 1,500 crores, with gross debt at INR 3,200 crores.
CapEx addition for the quarter was INR 180 crores, with a 65:35 split between tangible and intangible assets.
Exceptional loss of INR 3,232 million (US$37.75 million) related to US litigation settlement impacted reported PAT.
Outlook and guidance
Europe and emerging markets are expected to return to double-digit growth from Q2 FY26.
North America to see continued growth with new injectable and respiratory launches, including generic Flovent.
India business targets long-term CAGR of 10–15% over 3–5 years, with convergence of reported and secondary sales growth from Q3.
Gross margin of 68–69% and EBITDA margin of 23%+ are expected to be sustainable.
RYALTRIS® and QINHAYOT launches planned in new markets; innovation arm restructuring to align with long-term vision.
When will Europe return to double-digit growth?
What is the plan for the consumer business?
What is the expected timeline for the IFC deal?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Glenmark Pharmaceuticals earnings date
Q2 20267 Nov, 2025
Next Glenmark Pharmaceuticals earnings date
Q2 20267 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Glenmark Pharmaceuticals Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic and specialty medicines. The company operates across multiple therapeutic areas, including dermatology, respiratory, oncology, and cardiovascular diseases. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage